×
About 538 results

ALLMedicine™ Hallucinogens Center

Research & Reviews  191 results

Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiaze...
https://doi.org/10.1002/dta.3150
Drug Testing and Analysis; Niebel A, Westendorf L et. al.

Aug 27th, 2021 - Hair samples are frequently analyzed in order to characterize consumption patterns of drugs. However, the interpretation of new psychoactive substance (NPS) findings in hair remains difficult because of lacking data for comparison. In this study, ...

Effects of Dimethyltryptamine in Healthy Subjects
https://clinicaltrials.gov/ct2/show/NCT04353024

Aug 18th, 2021 - N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance widely used in recreational and spiritual settings in the form of Ayahuasca. Similar to lysergic acid diethylamide (LSD) or psilocybin, DMT is considered a tool to induce ...

Pharmacologic Similarities and Differences Among Hallucinogens.
https://doi.org/10.1002/jcph.1917
Journal of Clinical Pharmacology; Waters K

Aug 17th, 2021 - Hallucinogens constitute a unique class of substances that cause changes in the user's thoughts, perceptions, and mood through various mechanisms of action. Although the serotonergic hallucinogens such as lysergic acid diethylamide, psilocybin, an...

A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-...
https://doi.org/10.1093/jat/bkab075
Journal of Analytical Toxicology; Farley M, Tran H et. al.

Jun 24th, 2021 - Driving under the influence of drugs (DUID) cases continue to challenge forensic toxicologists as both the volume and complexity of casework increases. Comprehensive DUID testing should also meet the drafted ASB/ANSI standard and the NSC-ADID reco...

Examining the heterogeneity of polysubstance use patterns in young adulthood by age and...
https://doi.org/10.1037/pha0000472
Experimental and Clinical Psychopharmacology; Stevens AK, Gunn RL et. al.

May 11th, 2021 - Substance use in young adulthood and polysubstance users (PSU), in particular, pose unique risks for adverse consequences. Prior research on young adult PSU has identified multiple classes of users, but most work has focused on college students. W...

see more →

Clinicaltrials.gov  1 results

Effects of Dimethyltryptamine in Healthy Subjects
https://clinicaltrials.gov/ct2/show/NCT04353024

Aug 18th, 2021 - N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance widely used in recreational and spiritual settings in the form of Ayahuasca. Similar to lysergic acid diethylamide (LSD) or psilocybin, DMT is considered a tool to induce ...

see more →

News  23 results

Use of Marijuana, Meth, Hallucinogens Up in New SAMHSA Survey
https://www.medscape.com/viewarticle/917131

Aug 22nd, 2019 - Almost 1 million more Americans ages 12 or older reported using marijuana in their lifetime in 2018 than in 2017, according to new data from a national survey. The Substance Abuse and Mental Health Services Administration (SAMHSA) 2018 National Su...

USPSTF: Screen Adults for Illicit Drug Use
https://www.medpagetoday.com/primarycare/generalprimarycare/81563

Aug 13th, 2019 - Providers should screen all adult patients for illicit drug use when appropriate care is available, according to a U.S. Preventive Services Task Force (USPSTF) draft recommendation released on Tuesday. Available evidence provided the basis for a "...

Consider iatrogenesis in patients with new psychiatric symptoms
https://www.mdedge.com/familymedicine/article/203170/depression/consider-iatrogenesis-patients-new-psychiatric-symptoms?channel=39313
MDedge Psychiatry; Jeff Craven

Jun 19th, 2019 - CRYSTAL CITY, VA. – Be aware of the potential iatrogenic properties of medications prescribed when patients present with new psychiatric symptoms, Henry A.

Kratom: An Emerging Drug of Abuse
https://www.mdedge.com/emergencymedicine/article/136824/toxicology/kratom-emerging-drug-abuse
Hamid R. Tavakoli, MD, Andrew C. Buchholz, DO et. al.

May 4th, 2017 - Editor’s Note: This article has been adapted from an article originally published in Federal Practitioner (Tavakoli HR, et al. Kratom: a new product in an expanding substance abuse market.

Maddening therapies: How hallucinogens morphed into novel treatments
https://www.mdedge.com/psychiatry/article/126518/practice-management/maddening-therapies-how-hallucinogens-morphed-novel/page/0/2

Jan 1st, 2017 - Cannabis Last, but certainly not least, is marijuana, which is more widely used than all the other psychedelics combined, and is currently at the center of a national debate about its legalization. Although the director of the National Institute o.

see more →